TuSimple, a China and US-based developer of autonomous driving technology for trucks, has received equity funding from US truck manufacturer Navistar International and entered into a partnership with the company.
TuSimple, which was established in 2015 by California Institute of Technology graduate Xiaodi Hou, has raised more than $285 million from PE and VC investors. It achieved a valuation in excess of $1 billion...
Increased climate change awareness on a corporate level is leading to more investment – either direct or through funds – in start-ups that offer mitigation solutions. Asia is a key geography
Healthcare-focused Panacea Venture has led a $40 million Series C round for China’s XWPharma, a neurobiology-focused biotech developer previously known as XW Laboratories.
Kyee Technology, a Chinese digital medical platform has raised RMB430 million ($64 million) in a Series D round led by Tencent Holdings. Other investors include Longmen Capital, Dyee Capital and Royal Sea Capital.
Biocytogen, a Chinese contract research organization (CRO) that provides genetically-modified mice for drug testing, has raised RMB970 million ($143 million) in an extended tranche of Series D funding.